依普利酮国内能买到吗？在哪能买到？

Eplerenone is an important aldosterone receptor antagonist and plays a key role in the treatment of heart failure and hypertension in China. This article will explain to patients the domestic purchase channels, formal purchase channels and important precautions during use of eplerenone, and help patients use this drug safely and rationally.

Is eplerenone available in China

It has been officially launched in China and patients can purchase it through formal channels.

Domestic marketing status

Eplerenone was approved for marketing by the China National Medical Products Administration in 2020, with the trade name Eplerenone. Currently, it is a prescription drug in the country and needs to be purchased with a doctor’s prescription.

Drug specifications

Eplerenone on the domestic market mainly comes in two specifications: 25mg and 50mg, and the common packaging is 28 tablets/box. The drug instructions and packaging are marked in Chinese, making it easier for patients to read.

After understanding the drug listing situation, the following will introduce the specific purchase channels.

Where to buy eplerenone

Patients can purchase eplerenone through the following formal channels.

Hospital Pharmacy

Hospital cardiovascular specialty pharmacies usually stock eplerenone, and patients need to purchase it with a prescription issued by a cardiology or hypertension specialist.

Chain pharmacies

Eplerenone can be purchased with a prescription in large chain pharmacies. When purchasing, you need to check the drug approval number to confirm that it is a product from regular channels.

Online platform

Some qualified Internet hospital platforms provide online consultation and drug delivery services. You can also purchase eplerenone and obtain the drug by mail.

Precautions for the use of eplerenone

The following matters need to be paid special attention to when using eplerenone.

Risk of hyperkalemia

Patients with impaired renal function, proteinuria, diabetes, and patients receiving concurrent treatment with ACE, ARB, NSAID, and moderate CYP3A inhibitors are at higher risk of developing hyperkalemia, and serum potassium levels need to be monitored regularly during treatment.

Dose adjustment

The dose should be adjusted appropriately when hyperkalemia (5.5-5.9mEq/L) occurs. Patients who cannot avoid using moderate CYP3A inhibitors need to reduce the dose of eplerenone.

Usage for special groups

The elderly and patients with renal insufficiency should use it with caution. It is prohibited for those with creatinine clearance ≤30mL/min. Renal function and electrolytes need to be monitored closely during treatment.

Eplerenone is a prescription drug and must be evaluated by a professional physician before use, and relevant examinations and monitoring must be carried out regularly.